BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rudramurthy SM, Hoenigl M, Meis JF, Cornely OA, Muthu V, Gangneux JP, Perfect J, Chakrabarti A; ECMM and ISHAM. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries. Mycoses 2021;64:1028-37. [PMID: 34133816 DOI: 10.1111/myc.13335] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Vinay K, Rudramurthy SM, Dogra S. Emergence of Mucormycosis during COVID-19 Pandemic and Dermatological Manifestations. Indian Dermatol Online J 2021;12:493-6. [PMID: 34430451 DOI: 10.4103/idoj.idoj_406_21] [Reference Citation Analysis]
2 Pruthi H, Muthu V, Bhujade H, Sharma A, Baloji A, Ratnakara RG, Bal A, Singh H, Sandhu MS, Negi S, Chakrabarti A, Singhal M. Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature. Mycopathologia 2021. [PMID: 34936060 DOI: 10.1007/s11046-021-00610-9] [Reference Citation Analysis]
3 Zautner AE, Frickmann H, Podbielski A. Risk Assessment for Molds in the Vicinity of a Child Requiring Peritoneal Dialysis Living in a Rural Northern German Area. Microorganisms 2021;9:2292. [PMID: 34835418 DOI: 10.3390/microorganisms9112292] [Reference Citation Analysis]
4 Yagüe N, Gómez-Delgado L, Curto MÁ, Carvalho VSD, Moreno MB, Pérez P, Ribas JC, Cortés JCG. Echinocandin Drugs Induce Differential Effects in Cytokinesis Progression and Cell Integrity. Pharmaceuticals (Basel) 2021;14:1332. [PMID: 34959732 DOI: 10.3390/ph14121332] [Reference Citation Analysis]
5 Eldred LE, Thorn RG, Smith DR. Simple Matching Using QIIME 2 and RDP Reveals Misidentified Sequences and an Underrepresentation of Fungi in Reference Datasets. Front Genet 2021;12:768473. [PMID: 34899856 DOI: 10.3389/fgene.2021.768473] [Reference Citation Analysis]
6 Muthu V, Kumar M, Paul RA, Zohmangaihi D, Choudhary H, Rudramurthy SM, Panda NK, Pannu AK, Sharma N, Sharma S, Chakrabarti A, Agarwal R. Is there an association between zinc and COVID-19-associated mucormycosis? Results of an experimental and clinical study. Mycoses 2021;64:1291-7. [PMID: 34420245 DOI: 10.1111/myc.13365] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Salazar F, Bignell E, Brown GD, Cook PC, Warris A. Pathogenesis of Respiratory Viral and Fungal Coinfections. Clin Microbiol Rev 2021;:e0009421. [PMID: 34788127 DOI: 10.1128/CMR.00094-21] [Reference Citation Analysis]
8 Hoenigl M, Egger M, Boyer J, Schulz E, Prattes J, Jenks JD. Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study. Mycoses 2021. [PMID: 34252244 DOI: 10.1111/myc.13352] [Reference Citation Analysis]
9 Siddiqui R, Abouleish MY, Khamis M, Ibrahim T, Khan NA. Cerebral mucormycosis: intranasal route to deliver amphotericin B for effective management? Curr Med Res Opin 2021;:1-3. [PMID: 34726555 DOI: 10.1080/03007995.2021.2000779] [Reference Citation Analysis]
10 Garg RK, Malhotra HS, Pandey S. Neurological infections in 2021: a spotlight on India. Lancet Neurol 2022;21:17-8. [PMID: 34942126 DOI: 10.1016/S1474-4422(21)00415-4] [Reference Citation Analysis]
11 Muthu V, Rudramurthy SM, Chakrabarti A, Agarwal R. Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World. Mycopathologia 2021. [PMID: 34414555 DOI: 10.1007/s11046-021-00584-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Prakash H, Skiada A, Paul RA, Chakrabarti A, Rudramurthy SM. Connecting the Dots: Interplay of Pathogenic Mechanisms between COVID-19 Disease and Mucormycosis. J Fungi (Basel) 2021;7:616. [PMID: 34436155 DOI: 10.3390/jof7080616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Aranjani JM, Manuel A, Abdul Razack HI, Mathew ST. COVID-19-associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic's second wave in India. PLoS Negl Trop Dis 2021;15:e0009921. [PMID: 34793455 DOI: 10.1371/journal.pntd.0009921] [Reference Citation Analysis]
14 Drummond RA, Obar JJ. Editorial overview: Niche-specific and species-specific host-fungal interactions - how do they impact human health? Curr Opin Microbiol 2021;64:162-5. [PMID: 34696987 DOI: 10.1016/j.mib.2021.10.003] [Reference Citation Analysis]
15 Seidel D, Simon M, Sprute R, Lubnow M, Evert K, Speer C, Seeßle J, Khatamzas E, Merle U, Behrens C, Blau IW, Enghard P, Haas CS, Steinmann J, Kurzai O, Cornely OA. Results from a national survey on COVID-19-associated mucormycosis in Germany: 13 patients from six tertiary hospitals. Mycoses 2021. [PMID: 34655486 DOI: 10.1111/myc.13379] [Reference Citation Analysis]
16 Singh R, Kumari A. Nasal Microbiota Imbalance as a Contributory Link in the Emergence of COVID-19 Associated Mucormycosis. ACS Infect Dis 2021;7:2211-3. [PMID: 34328718 DOI: 10.1021/acsinfecdis.1c00371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Lai CC, Wu CJ, Lee YC, Liu WL. COVID-19 associated with concomitant mucormycosis and aspergillosis. J Microbiol Immunol Infect 2021:S1684-1182(21)00187-0. [PMID: 34563471 DOI: 10.1016/j.jmii.2021.09.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Kumar H M, Sharma P, Rudramurthy SM, Sehgal IS, Prasad KT, Pannu AK, Das R, Panda NK, Sharma N, Chakrabarti A, Agarwal R, Muthu V. Serum iron indices in COVID-19-associated mucormycosis: A case-control study. Mycoses 2021. [PMID: 34743358 DOI: 10.1111/myc.13391] [Reference Citation Analysis]
19 Banerjee I, Robinson J, Asim M, Sathian B, Banerjee I. Mucormycosis and COVID-19 an epidemic in a pandemic? Nepal J Epidemiol 2021;11:1034-9. [PMID: 34290893 DOI: 10.3126/nje.v11i2.37342] [Reference Citation Analysis]
20 Mehrabi Z, Salimi M, Niknam K, Mohammadi F, Mamaghani HJ, Sasani MR, Ashraf MJ, Salimi A, Zahedroozegar MH, Erfani Z. Sinoorbital Mucormycosis Associated with Corticosteroid Therapy in COVID-19 Infection. Case Rep Ophthalmol Med 2021;2021:9745701. [PMID: 34745674 DOI: 10.1155/2021/9745701] [Reference Citation Analysis]
21 Casalini G, Giacomelli A, Ridolfo A, Gervasoni C, Antinori S. Invasive Fungal Infections Complicating COVID-19: A Narrative Review. J Fungi (Basel) 2021;7:921. [PMID: 34829210 DOI: 10.3390/jof7110921] [Reference Citation Analysis]
22 Garg M, Prabhakar N, Muthu V, Farookh S, Kaur H, Suri V, Agarwal R. CT Findings of COVID-19-associated Pulmonary Mucormycosis: A Case Series and Literature Review. Radiology 2022;302:214-7. [PMID: 34463553 DOI: 10.1148/radiol.2021211583] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
23 Guzmán-Castro S, Chora-Hernandez LD, Trujillo-Alonso G, Calvo-Villalobos I, Sanchez-Rangel A, Ferrer-Alpuin E, Ruiz-Jimenez M, Corzo-Leon DE. COVID-19-associated mucormycosis, diabetes and steroid therapy: Experience in a single centre in Western Mexico. Mycoses 2022;65:65-70. [PMID: 34674319 DOI: 10.1111/myc.13383] [Reference Citation Analysis]
24 Chang CY, Gan YL, Zamri FI, P. Radhakrishnan A. Rhino-orbital Mucormycosis in a COVID-19 Patient: The First Case in Malaysia. Proceedings of Singapore Healthcare. [DOI: 10.1177/20101058221074112] [Reference Citation Analysis]